Chemical Control of Fibrinolysis-thrombolysis PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Chemical Control of Fibrinolysis-thrombolysis PDF full book. Access full book title Chemical Control of Fibrinolysis-thrombolysis by Joseph M. Schor. Download full books in PDF and EPUB format.
Author: Joseph M. Schor
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 358
Get Book Here
Book Description
Author: Joseph M. Schor
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 358
Get Book Here
Book Description
Author: John Forsyth Davidson
Publisher:
ISBN: 9780443019722
Category : Medical
Languages : en
Pages : 552
Get Book Here
Book Description
Author: Kurt Nikolai Kaulla
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 362
Get Book Here
Book Description
Author:
Publisher:
ISBN:
Category : Blood
Languages : en
Pages : 562
Get Book Here
Book Description
Author: Kurt Nikolai Kaulla
Publisher: Charles C. Thomas Publisher
ISBN:
Category : Medical
Languages : en
Pages : 520
Get Book Here
Book Description
Author: John Forsyth Davidson
Publisher:
ISBN: 9788291003337
Category :
Languages : en
Pages : 200
Get Book Here
Book Description
Author: Krasimir Kolev
Publisher: BoD – Books on Demand
ISBN: 9535112651
Category : Medical
Languages : en
Pages : 210
Get Book Here
Book Description
This book familiarizes the reader with some recent trends in the theory and practice of thrombolysis. It covers the field of fibrinolysis from the standpoint of basic scientists and clinicians and delivers the state-of-the-art information on the biochemistry and pharmacology of fibrinolysis, as well as related novel methodological and diagnostic tools in the field. An introductory chapter summarizes the basic molecular mechanisms in fibrinolysis (plasminogen, its endogenous activators and their inhibitors, plasmin and its inhibitors). Recent developments in our understanding of fibrin formation are described in the context of its impact on fibrinolysis. The discussion of neutrophil extracellular traps in the modulation of fibrin assembly and the consequences regarding plasminogen activation and plasmin action addresses a novel aspect of fibrinolysis.
Author: Sol Sherry
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 344
Get Book Here
Book Description
The therapeutic benefits of controlling the fibrinolytic process are becoming well known. Its implications for and applications to clinical medicine continue to expand, and this book aims to provide a review of this therapeutic measure. It presents recent information on the subject: basic science of fibrinolysis, thrombosis and haemostasis; the rationale underlying the the activation and inhibition of the fibrinolytic enzyme system in the management of a variety of thrombotic and haemostatic disorders; evaluation of the clinical benefits and adverse reactions associated with thrombolytic agents; and guidelines for patient selection, drug administration, management and follow-up therapy.
Author: Richard C. Becker
Publisher: Oxford University Press, USA
ISBN: 0195155645
Category : Medical
Languages : en
Pages : 421
Get Book Here
Book Description
Thrombotic disorders of the circulatory system represent the leading cause of morbidity, motality, and health care expenditure in the United States. Fibrinolytic and Antithrombotic Therapy provides a practical, evidence-based approach to the management of thrombotic disorders for all clinicians involved in the care of patients with these disorders. It provides not only vital conceptual information on fibrinolytic and antithrombotic therapy, but also the means to apply it to everyday decision making and patient care. Focusing on managment guidelines and critical pathways, the text stresses practicality and usability. It will be a valuable resource for the wide range of clinicians involved in the care of patients with these disorders, including cardiologists, emergency physicians, primary care physicians, hematologists, neurologists, intensivists, pharmacists, and nurse practitioners. The origins of mammalian blood coagulation can be traced back over 400 million years. Despite its long history, it is only within the past century that this complex and pivotal teleologic system has begun to be understood. Most recently, the intricacies of hemostasis and pahtologic thrombosis have come to light, leading the way toward new, more effective, and safer treatment modalities. The Second Edition of Fibrinolytic and Antithrombotic Therapy, even more concise and clinically relevant than the First, provides vital, evidence-based information on management of patients with arterial and venous thrombotic disorders. Since the First Edition, the text has been expanded to cover the evolving topics of atherothrombosis, thrombocardiology, hematologic/thrombophilic conditions, and vascular medicine. It includes up-to-date guidelines for antithrombotic and fibrinolytic therapy, and offers concise summaries of current "standards of care." Chapters are dedicated to discussions of patient-specific therapeutics and to the importance of genomics, proteomics, and metabolomics in defining genotype-phenotype relationships, while throughout the book coagulation, inflammation, and vascular medicine are newly examined as elements in an intricatley-linked triad of biochemical and cellular based phenomenology.
Author: Pia Glas-Greenwalt
Publisher: CRC Press
ISBN: 9780849360800
Category : Medical
Languages : en
Pages : 286
Get Book Here
Book Description
Fibrinolysis in Disease reviews the state of the art of basic and clincal aspects of the fibrinolytic enzyme system. The text, authored by outstanding and internationally known investigators, is presented in two books. The Malignant Process, Interventions in Thrombogenic Mechanisms, and Novel Treatment Modalities discuses the molecular biology of the system's key components and their fundamental roles in a variety of thrombotic and metabolic disorders. Molecular and Hemovascular Aspects of Fybrinolysis presents the latest findings and concepts of the association between plasminogen activator (u-PA) overexpression and abnormal growth regulation in a variety of solid tumors and in leukemia. One chapter deals with various successful interventions in thrombogenic mechanisms, ranging from exercise and diet to anticoagulants and direct and indirect thrombolytic agents. It concludes with a projection of exciting, novel treatment modalities in thrombotic and malignant diseases.
